Anebulo Pharmaceuticals Inc (ANEB) Stock Price

0.4347 ▼ -0.0383 (-8.10%)
Open: 0.48 Vol: 0 Day's range: 0.41 - 0.4932 Feb 23, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
ANEB Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 0.44▼ 0.45▼ 0.45▼ 0.47▼ 0.59▼
MA10 0.46▼ 0.46▼ 0.46▼ 0.47▼ 0.85▼
MA20 0.47▼ 0.47▼ 0.47▼ 0.68▼ 1.63▼
MA50 0.64▼ 0.71▼ 0.73▼ 1.13▼ 1.72▼
MA100 0.83▼ 0.89▼ 0.91▼ 1.79▼ 1.85▼
MA200 1.01▼ 1.41▼ 1.60▼ 1.86▼ 2.33▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.009▲ 0.013▲ 0.014▲ 0.008▲ -0.164▼
RSI 28.386▼ 23.830▼ 22.751▼ 20.408▼ 22.713▼
STOCH 3.414▼ 26.901     26.901     19.516▼ 6.129▼
WILL %R -89.931▼ -89.931▼ -89.931▼ -95.667▼ -98.813▼
CCI -127.942▼ -159.660▼ -164.447▼ -58.314     -95.318    
Latest Filters Detected On ANEB
▼ BREAK $ANEB Price Breaks 60 Days Low Set Alert
▼ BREAK $ANEB Price Breaks 30 Days Low Set Alert
▼ BREAK $ANEB Price Breaks 20 Days Low Set Alert
▼ BREAK $ANEB Price Breaks 10 Days Low Set Alert
CDL $ANEB Engulfing Candlestick Pattern Detected Set Alert
Anebulo Pharmaceuticals Inc News
Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Updates
Thursday, February 12, 2026 01:37 PM
Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the "Company" or ...
Anebulo Pharmaceuticals Announces Intention to Voluntarily Delist from Nasdaq and Deregister with SEC
Friday, February 06, 2026 06:00 AM
AUSTIN, Texas--(BUSINESS WIRE)-- Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic ...
Anebulo Pharmaceuticals Announces Final Results of Tender Offer
Sunday, January 25, 2026 04:00 PM
AUSTIN, Texas--(BUSINESS WIRE)-- Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic ...
ANEB historical stock data
date open high low close volume
23/02/26 0.48 0.4932 0.41 0.4347 0
20/02/26 0.46 0.4798 0.45 0.473 121,725
19/02/26 0.48 0.5055 0.46 0.4833 65,001
18/02/26 0.472 0.50 0.472 0.4892 43,245
17/02/26 0.472 0.499 0.472 0.481 31,736
13/02/26 0.4665 0.4999 0.465 0.479 42,534
12/02/26 0.4689 0.4849 0.465 0.4749 29,481
11/02/26 0.4702 0.477 0.46 0.4747 25,138
10/02/26 0.4624 0.483 0.46 0.476 39,066
09/02/26 0.4699 0.50 0.46 0.4815 140,003
Quote Details
52wk Low:0.41
52wk High:3.42
Vol:0
Avg Vol(3m):1.8M
1Y Chng:-68.73%
1M Chng:-61.87%
Add to Watch List
More Information
Index US Composite
Market Cap. 19.29M